Company Spotlight

Almac Group

Almac House, 20 Seagoe Industrial Estate
Armagh, BT63 5QD
United Kingdom
View Profile

Aphena Pharma Solutions

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


Origin Pharma Packaging





Company Headquarters

Melton House, Jackson Way
Melton, HU14 3HJ
United Kingdom

Contract Service Directory

    Related Content

    • Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
      Foamix Enters Contract Manufacturing Agreement

      Foamix Enters Contract Manufacturing Agreement

      Signs manufacturing and supply deal with ASM for AMZEEQ and FMX103.
      10.23.19

    • Like It’s 1999

      Like It’s 1999

      Reflecting on 20 years of Contract Pharma.
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 10.15.19

    • A Witness to the Growth of Outsourcing

      A Witness to the Growth of Outsourcing

      Observations from the 2019 Contract Pharma Conference.
      Emil W. Ciurczak, DoraMaxx Consulting 10.15.19


    • APIs
      Better Drug Manufacturing Strategies: Custom APIs

      Better Drug Manufacturing Strategies: Custom APIs

      Today’s biopharma companies are turning to their contractors for long-term collaboration and much higher levels of support.
      Tom Wilson, VP, Global Contract Manufacturing Leader, Pfizer CentreOne 10.15.19

    • APIs | cGMP Manufacture | Clinical Trial Materials | Custom Sourcing News | Industry News
      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)
      10.07.19

    • Clinical Trials | Serialization | Supply Chain
      Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

      Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

      Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it.
      Ben Locwin, Healthcare Science Advisors 10.04.19


    • Cytotoxics and High Potency Manufacturing
      API to ADC: A Journey Through High Potency

      API to ADC: A Journey Through High Potency

      This class of compounds represents a major advance in oncology research and treatment application.
      Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19

    • cGMP Manufacture | Industry News
       Opiant Pharmaceuticals, Sanofi to Manufacture Acute Cannabinoid Overdose Treatment

      Opiant Pharmaceuticals, Sanofi to Manufacture Acute Cannabinoid Overdose Treatment

      Opiant’s drinabant, selective cannabinoid receptor antagonist, could be first approved treatment for ACO
      07.24.19

    • Breaking News | Excipients | Facilities | Industry News
      Colorcon Expands Excipients Business

      Colorcon Expands Excipients Business

      To build starch manufacturing plant near Amsterdam
      07.15.19


    • Collaborations & Alliances | Drug Development
      Gilead and Nurix to Collaborate on Novel Therapies

      Gilead and Nurix to Collaborate on Novel Therapies

      Consisting of targeted protein degradation drugs for patients with cancer and other challenging diseases
      06.20.19

    • Breaking News | Industry News | Information Technology | Packaging & Tracking | Supply Chain
      Central Pharma Partners with Veratrak

      Central Pharma Partners with Veratrak

      Software provider to help CPO digitize supply chain operations
      05.28.19

    • Drug Delivery | Industry News
      Lonza Launches Capsugel Zephyr DPI Portfolio

      Lonza Launches Capsugel Zephyr DPI Portfolio

      Includes a portfolio of high-quality, customizable DPI capsules of different polymers and compositions, and product customization services
      05.17.19


    • Drug Development | Preclinical Outsourcing
      New Drug Development Strategies Needed for Alzheimer’s Treatments

      New Drug Development Strategies Needed for Alzheimer’s Treatments

      Selecting a single CRO partner that can take CNS compounds from functional screening in vitro through in vivo and beyond
      Birgit Hutter-Paier, Senior Director and Head of Neuropharmacology, QPS 05.10.19

    • cGMP Manufacture
      Manufacturing Strategy Keys for Success

      Manufacturing Strategy Keys for Success

      One size fits all is rarely an appropriate drug manufacturing strategy.
      Oskar Gold, Vetter Pharma International GmbH 05.07.19